Cargando…
Platelet‐specific antibodies and differences in their expression in childhood immune thrombocytopenic purpura predicts clinical progression
IMPORTANCE: Immune thrombocytopenic purpura (ITP) is the most common bleeding disorder in children. Despite the highly spontaneously remission, still almost 20% of cases progress into chronic or refractory ITP, which seriously affects children's quality of life. Currently there is no method to...
Autores principales: | Fu, Lingling, Ma, Jie, Cheng, Zhengping, Gu, Hao, Ma, Jingyao, Wu, Runhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331365/ https://www.ncbi.nlm.nih.gov/pubmed/32851271 http://dx.doi.org/10.1002/ped4.12097 |
Ejemplares similares
-
Assessment of Regulatory T Cells in Childhood Immune Thrombocytopenic Purpura
por: Mazzucco, Karina L. M., et al.
Publicado: (2013) -
Immune thrombocytopenic purpura
por: Zainal, Abir, et al.
Publicado: (2019) -
Importance of immature platelet fraction as predictor of immune thrombocytopenic purpura
por: Naz, Arshi, et al.
Publicado: (2016) -
Identification and Characterization of Anti-Platelet Antibodies in Idiopathic Thrombocytopenic Purpura Patients
por: Aghabeigi, N, et al.
Publicado: (2012) -
Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023)